PATENT CLAIM ANALYSIS

Application Number: 15971983
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "130100"]

Abstract:
Agonists to ICOS in combination with a blocking agent to a T cell inhibitory receptor (e.g., CTLA-4, PD-1, etc.) are demonstrated herein to be useful for the treatment of tumors.

Claim (Index 6):
The method of  claim 3 , wherein the blocking anti-CTLA-4 antibody is a humanized antibody.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 93.0
- Lexical Diversity: 1.19355
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14250272', '13498570', '15006560', '15387161', '15246662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8122700066811755
- 35 USC 102 Novelty (BERT): 0.619672883686119
- Combined Prediction Score: 0.7930102943816699
- Mean Citation Score: 483.005988
- Max Citation Score: 678.41895
- Similarity Product: 493.3504871010304

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test